Disruption of laboratory activities during the COVID-19 pandemic : results of an EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) survey
Copyright © 2023 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved..
Background: The EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) created a survey that has been distributed to its members for gathering information on the key hazards experienced by European medical laboratories during the COVID-19 pandemic.
Methods: The survey was distributed to over 12,000 potential contacts (laboratory workers) via an EFLM newsletter, with responses collected between May 8 and June 8, 2023.
Results: Two hundred replies were collected and examined from European laboratories. 69.7% and 78.1% of all responders said they were short on non-COVID and COVID reagents, respectively. Exactly half of respondents (50.0%) said that they could not complete all laboratory tests required for a specific period, but this figure climbed to 61.2% for COVID tests. Finally, 72.3% of respondents expressed exhaustion during the pandemic, and 61.2% reported increasing patient hostility.
Conclusions: The COVID-19 pandemic had a significant impact on laboratory medicine in Europe. Cultural change, proactive planning, and even re-engineering in some parts of the laboratory industry may thus be necessary to prepare for future challenges.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
EJIFCC - 34(2023), 3 vom: 11. Okt., Seite 213-219 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lippi, Giuseppe [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 31.10.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM363603913 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363603913 | ||
003 | DE-627 | ||
005 | 20231226093711.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n1211.xml |
035 | |a (DE-627)NLM363603913 | ||
035 | |a (NLM)37868082 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lippi, Giuseppe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Disruption of laboratory activities during the COVID-19 pandemic |b results of an EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) survey |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 31.10.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2023 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. | ||
520 | |a Background: The EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) created a survey that has been distributed to its members for gathering information on the key hazards experienced by European medical laboratories during the COVID-19 pandemic | ||
520 | |a Methods: The survey was distributed to over 12,000 potential contacts (laboratory workers) via an EFLM newsletter, with responses collected between May 8 and June 8, 2023 | ||
520 | |a Results: Two hundred replies were collected and examined from European laboratories. 69.7% and 78.1% of all responders said they were short on non-COVID and COVID reagents, respectively. Exactly half of respondents (50.0%) said that they could not complete all laboratory tests required for a specific period, but this figure climbed to 61.2% for COVID tests. Finally, 72.3% of respondents expressed exhaustion during the pandemic, and 61.2% reported increasing patient hostility | ||
520 | |a Conclusions: The COVID-19 pandemic had a significant impact on laboratory medicine in Europe. Cultural change, proactive planning, and even re-engineering in some parts of the laboratory industry may thus be necessary to prepare for future challenges | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Laboratory Medicine | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Survey | |
700 | 1 | |a Cadamuro, Janne |e verfasserin |4 aut | |
700 | 1 | |a Danese, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Favaloro, Emmanuel J |e verfasserin |4 aut | |
700 | 1 | |a Favresse, Julien |e verfasserin |4 aut | |
700 | 1 | |a Henry, Brandon M |e verfasserin |4 aut | |
700 | 1 | |a Jovicic, Snezana |e verfasserin |4 aut | |
700 | 1 | |a Ozben, Tomris |e verfasserin |4 aut | |
700 | 1 | |a Plebani, Mario |e verfasserin |4 aut | |
700 | 1 | |a Thachil, Jecko |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t EJIFCC |d 1999 |g 34(2023), 3 vom: 11. Okt., Seite 213-219 |w (DE-627)NLM264815653 |x 1650-3414 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2023 |g number:3 |g day:11 |g month:10 |g pages:213-219 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2023 |e 3 |b 11 |c 10 |h 213-219 |